ADC Therapeutics SA

ADCT

...

ADCT: ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

Show ADCT Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of ADCT by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by ADCT's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on ADCT's company Twitter account

WallStreetBets

Number of mentions of ADCT in WallStreetBets Daily Discussion

ADCT News

Recent insights relating to ADCT

CNBC Recommendations

Recent picks made for ADCT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ADCT

Corporate Flights

Flights by private jets registered to ADCT